Status:
COMPLETED
Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma
Lead Sponsor:
Associated Scientists to Help Minimize Allergies
Collaborating Sponsors:
Benaroya Research Institute
GlaxoSmithKline
Conditions:
Allergic Asthma
Eligibility:
All Genders
18-45 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine the role of versican and hyaluronan measurements in induced sputum as biomarkers of asthma. Enroll 10 subjects with mild persistent asthma who are not receivi...
Detailed Description
We will compare spirometry, eNO and sputum measurements of versican and hyaluronan before and after treatment with fluticasone 220 ug/bid.
Eligibility Criteria
Inclusion
- Allergic asthma defined as a positive methacholine challenge
Exclusion
- Non-atopic patients
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00980707
Start Date
August 1 2009
End Date
November 1 2010
Last Update
January 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Associated Scientists to Help Minimize Allergies
Seattle, Washington, United States, 98105